VITL Secures $7.5M Funding to Revolutionize Cash-Pay Clinic Prescribing Amidst GLP-1 Boom

VITL has successfully raised $7.5 million in funding, aiming to transform cash-pay clinic prescribing practices, particularly capitalizing on the growing popularity of GLP-1 medications.